NOVN Description — Novan Inc

Novan is a pharmaceutical company focused on dermatology and anti-infective therapies. Co. has clinical-stage dermatology and anti-infective drug candidates with multi-factorial (SB204), anti-viral (SB206), anti-fungal (SB208), and anti-inflammatory (SB414) mechanisms of action. Co. has also introduced a possible anti-viral product candidate for the treatment of external genital warts (SB207). Co. has conducted or is conducting preclinical work on new chemical entities, including berdazimer sodium, and formulations for the potential treatment of SARS-CoV-2, the virus that causes COVID-19 (SB019); and antimicrobial indications for the adjacent companion animal health market (NVN4100).

Company Name: 
Novan Inc
Drugs & Pharmaceuticals
Number of ETFs Holding NOVN: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   NOVN Weight   NOVN Amount 
 VTI   0.00%   $711,696         
 IWC   0.01%   $51,692         
 EFAD   0.02%   $21,211         
 ITOT   0.00%   $19,987         
 EUDV   0.04%   $3,572         
Quotes delayed 20 minutes

Email EnvelopeFree NOVN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (4.00 out of 4)
82nd percentile
(ranked higher than approx. 82% of all stocks covered)
Based on data provided by Zacks Investment Research via

ETFs Holding NOVN | Novan Inc | ETF Channel |

Copyright © 2010 - 2022, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.